Select Medical (NYSE:SEM) Issues FY 2024 Earnings Guidance

Select Medical (NYSE:SEM) issued an update on its FY 2024 earnings guidance on Thursday morning. The company provided earnings per share guidance of 2.090-2.200 for the period, compared to the consensus earnings per share estimate of 1.860. The company issued revenue guidance of $7.0 billion-$7.2 billion, compared to the consensus revenue estimate of $7.0 billion.

Select Medical Stock Down 2.6 %

NYSE SEM traded down $0.84 on Thursday, reaching $32.01. The company had a trading volume of 946,954 shares, compared to its average volume of 597,744. Select Medical has a 52-week low of $21.28 and a 52-week high of $40.50. The company’s fifty day moving average is $34.30 and its 200 day moving average is $33.93. The company has a quick ratio of 1.09, a current ratio of 1.09 and a debt-to-equity ratio of 2.11. The stock has a market capitalization of $4.16 billion, a P/E ratio of 15.71, a P/E/G ratio of 1.96 and a beta of 1.41.

Select Medical (NYSE:SEM) last posted its quarterly earnings results on Thursday, August 1st. The health services provider reported $0.60 earnings per share for the quarter, missing the consensus estimate of $0.61 by ($0.01). The business had revenue of $1.76 billion during the quarter, compared to analysts’ expectations of $1.74 billion. Select Medical had a return on equity of 17.50% and a net margin of 3.91%. The firm’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $0.61 EPS. Sell-side analysts anticipate that Select Medical will post 2.03 earnings per share for the current fiscal year.

Analysts Set New Price Targets

SEM has been the subject of several analyst reports. Bank of America started coverage on shares of Select Medical in a research note on Tuesday, August 20th. They issued a “buy” rating and a $42.00 price target for the company. Benchmark reaffirmed a “buy” rating and issued a $48.00 price target on shares of Select Medical in a report on Friday, September 6th. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $39.00.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.